Correlation Engine 2.0
Clear Search sequence regions


  • female (1)
  • fetal growth (1)
  • homeostasis (1)
  • humans (1)
  • insulin (14)
  • IR (4)
  • IRS 1 (3)
  • kinases (1)
  • litter size (1)
  • liver (2)
  • low (3)
  • LRP6 (14)
  • lrp6 protein, rat (1)
  • mTOR (5)
  • protein rat (1)
  • rapamycin (1)
  • rats (8)
  • receptor insulin (2)
  • regulates (1)
  • S6K (8)
  • tor kinases (1)
  • β catenin (5)
  • Sizes of these terms reflect their relevance to your search.

    Intrauterine growth restriction followed by postnatal catch-up growth (CG-IUGR) increases the risk of insulin resistance-related diseases. Low-density lipoprotein receptor-related protein 6 (LRP6) plays a substantial role in glucose metabolism. However, whether LRP6 is involved in the insulin resistance of CG-IUGR is unclear. This study aimed to explore the role of LRP6 in insulin signaling in response to CG-IUGR. The CG-IUGR rat model was established via a maternal gestational nutritional restriction followed by postnatal litter size reduction. The mRNA and protein expression of the components in the insulin pathway, LRP6/β-catenin and mammalian target of rapamycin (mTOR)/S6 kinase (S6K) signaling, was determined. Liver tissues were immunostained for the expression of LRP6 and β-catenin. LRP6 was overexpressed or silenced in primary hepatocytes to explore its role in insulin signaling. Compared with the control rats, CG-IUGR rats showed higher homeostasis model assessment for insulin resistance (HOMA-IR) index and fasting insulin level, decreased insulin signaling, reduced mTOR/S6K/ insulin receptor substrate-1 (IRS-1) serine307 activity, and decreased LRP6/β-catenin in the liver tissue. The knockdown of LRP6 in hepatocytes from appropriate-for-gestational-age (AGA) rats led to reductions in insulin receptor (IR) signaling and mTOR/S6K/IRS-1 serine307 activity. In contrast, LRP6 overexpression in hepatocytes of CG-IUGR rats resulted in elevated IR signaling and mTOR/S6K/IRS-1 serine307 activity. LRP6 regulated the insulin signaling in the CG-IUGR rats via two distinct pathways, IR and mTOR-S6K signaling. LRP6 may be a potential therapeutic target for insulin resistance in CG-IUGR individuals. © 2023. Huazhong University of Science and Technology.

    Citation

    Xue-Mei Xie, Qiu-Li Cao, Yu-Jie Sun, Jie Zhang, Kai-Li Liu, Ying-Fen Qin, Wen-Jun Long, Zuo-Jie Luo, Xiao-Wei Li, Xing-Huan Liang, Guan-Dou Yuan, Xiao-Ping Luo, Xiu-Ping Xuan. LRP6 Bidirectionally Regulates Insulin Sensitivity through Insulin Receptor and S6K Signaling in Rats with CG-IUGR. Current medical science. 2023 Apr;43(2):274-283

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36913109

    View Full Text